Evaluation of teplizumab's efficacy and safety in treatment of type 1 diabetes mellitus: A systematic review and meta-analysis

被引:3
作者
Ma, Xiao-Lan [1 ]
Ge, Dan [1 ]
Hu, Xue-Jian [1 ]
机构
[1] Lanzhou Univ, Dept Endocrinol & Metab, Hosp 2, Lanzhou 730030, Gansu, Peoples R China
关键词
Type-1 diabetes mellitus; Teplizumab; Anti-CD3 monoclonal antibody; Insulin; Glycated haemoglobin A1c; C-peptide; C-PEPTIDE; THERAPIES;
D O I
10.4239/wjd.v15.i7.1615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Islets of Langerhans beta cells diminish in autoimmune type 1 diabetes mellitus (T1DM). Teplizumab, a humanized anti-CD3 monoclonal antibody, may help T1DM. Its long-term implications on clinical T1DM development, safety, and efficacy are unknown. AIM To assess the effectiveness and safety of teplizumab as a therapeutic intervention for individuals with T1DM. METHODS A systematic search was conducted using four electronic databases (PubMed, Embase, Scopus, and Cochrane Library) to select publications published in peer-reviewed journals written in English. The odds ratio (OR) and risk ratio (RR) were calculated, along with their 95%CI. We assessed heterogeneity using Cochrane Q and I2 statistics and the appropriate P value. RESULTS There were 8 randomized controlled trials (RCTs) in the current meta-analysis with a total of 1908 T1DM patients from diverse age cohorts, with 1361 patients receiving Teplizumab and 547 patients receiving a placebo. Teplizumab was found to have a substantial link with a decrease in insulin consumption, with an OR of 4.13 (95%CI: 1.72 to 9.90). Teplizumab is associated with an improved C-peptide response (OR 2.49; 95%CI: 1.62 to 3.81) and a significant change in Glycated haemoglobin A1c (HbA1c) levels in people with type 1 diabetes [OR 1.75 (95%CI: 1.03 to 2.98)], and it has a RR of 0.71 (95%CI: 0.53 to 0.95). CONCLUSION In type 1 diabetics, teplizumab decreased insulin consumption, improved C-peptide response, and significantly changed HbA1c levels with negligible side effects. Teplizumab appears to improve glycaemic control and diabetes management with good safety and efficacy.
引用
收藏
页数:13
相关论文
共 50 条
[31]   Therapeutic Effects of BCG Vaccination on Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].
Chang, Yu-Chen ;
Lin, Chien-Ju ;
Hsiao, Yu-Hsuan ;
Chang, Yu-Han ;
Liu, Shu-Jung ;
Hsu, Hsin-Yin .
JOURNAL OF DIABETES RESEARCH, 2020, 2020
[32]   Stem cell transplantation for the treatment of patients with type 1 diabetes mellitus: A meta-analysis [J].
Gan, Jiadi ;
Wang, Yingjin ;
Zhou, Xiaodong .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (06) :4479-4492
[33]   Probiotics, prebiotics, and synbiotics in type 1 diabetes mellitus: A systematic review and meta-analysis of clinical trials [J].
Moravejolahkami, Amir Reza ;
Shakibaei, Mehdi ;
Fairley, Andrea Mary ;
Sharma, Manoj .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (02)
[34]   Efficacy and Safety of Insulin Degludec/Insulin Aspart (IDegAsp) in Type 2 Diabetes: Systematic Review and Meta-Analysis [J].
Edina, Brenda C. ;
Tandaju, Jeremy R. ;
Wiyono, Lowilius .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
[35]   Efficacy and safety of acarbose combined with insulin in treatment of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials [J].
Hu, Haiying ;
Zheng, Jia ;
Chen, Xian ;
Jiang, Diying ;
Sun, Xiaomeng ;
Qian, Yingying ;
Zhang, Yan ;
Chen, Jingsen .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (11) :15071-15079
[36]   Liraglutide as Adjunct to Insulin Treatment in Patients with Type 1 Diabetes: A Systematic Review and Meta-analysis [J].
Dimitrios, Patoulias ;
Michael, Doumas ;
Vasilios, Kotsis ;
Konstantinos, Stavropoulos ;
Konstantinos, Imprialos ;
Ioanna, Zografou ;
Konstantinos, Petidis ;
Spyridon, Bakatselos ;
Asterios, Karagiannis .
CURRENT DIABETES REVIEWS, 2020, 16 (04) :313-326
[37]   Clinical efficacy of stem-cell therapy on diabetes mellitus: A systematic review and meta-analysis [J].
Pires, Isabella Gouveia Santos ;
Silva e Souza, Jose Arthur ;
Bisneto, Abel Vieira de Melo ;
Passos, Xisto Sena ;
Carneiro, Cristiene Costa .
TRANSPLANT IMMUNOLOGY, 2022, 75
[38]   Efficacy and Safety of Bromocriptine-QR as an Adjunctive Therapy on Glycemic Control in Subjects with Uncontrolled Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis [J].
Yanto, Theo Audi ;
Budiputri, Charista Lydia ;
Muljono, Michelle Patricia ;
Chandra, Shally .
JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2024, 39 (01) :95-105
[39]   Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A meta-analysis and meta-regression [J].
Deyno, Serawit ;
Eneyew, Kassahun ;
Seyfe, Sisay ;
Tuyiringire, Naasson ;
Peter, Emanuel L. ;
Muluye, Rekik Ashebir ;
Tolo, Casim Umba ;
Ogwang, Patrick Engeu .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 156
[40]   Current Status of Metabolic/Bariatric Surgery in Type 1 Diabetes Mellitus: an Updated Systematic Review and Meta-analysis [J].
Kermansaravi, Mohammad ;
Valizadeh, Rohollah ;
Jazi, Amirhossein Davarpanah ;
Shahmiri, Shahab Shahabi ;
Lopez Martinez, Jose Antonio ;
Mousavimaleki, Ali ;
Eghbali, Foolad ;
Aliakbar, Amirhossein ;
Atarodi, Hamed ;
Aghajani, Ebrahim ;
Lainas, Panagiotis .
OBESITY SURGERY, 2022, 32 (05) :1726-1733